FelixHoffman Speaks: The day is Upon us
Dr Paul Ladenson, Director of Endocrinology at Johns Hopkins, Past multiple year President of the American Thyroid Association, 5 years Editor in Chief of the Journal of Clinical Endocrinology and Metabolism (JCEM) and along with being regarded as one of the top endocrinologists in the world, a known and published "Anatabine Researcher", The good doctor is about to transcend his platinum reputation as the author of one of the most important break through discoveries in modern medicine. A 150 patient human clinical trial is about to be published which will show that anatabine can "ameliorate", reverse, normalize, one of the top auto-immune diseases in the world, which affects 13-20mn people in the US alone. But more importantly, this study will prove that anatabine is the most balanced, systemically safe, and most effective anti-inflammatory on the planet. 4-7 X more powerful than aspirin, ibuprofen, celebrex, voltaren,etc..... If one reads all of the clinical manuscripts for anatabine, all of the material and publicly available information on the compound. Take the compound yourself. Try it! IT IS A FORGONE CONCLUSION. If you call JCEM the Endocrinology Journal, JAMA, the NEJof Medicine....., The average submission to publication is 2-3 months. As the former Editor in Chief of JCEM, do you think Dr. Ladenson knows how to submit a scientific manuscript? As former Editor in Chief of JCEM, and current Director of Endocrinology At Hopkins, You can rest assure that he would not be wasting his time on some peripheral, abstract initiative that would have little to no clinical value. We are going to here ANY DAY, about a compound worth $1bn+ just for thyroid alone. Oh, by the way, the aches and pains anti-inflammatory market (aspirin, motrin, celebrex, etc....) Is already worth 15bn, in and of itself. Ladies and gentleman, WE ARE ABOUT TO BE MONETIZED.
(Hold on to your Butt Cheeks Shorty) ANY DAY NOW!
Sentiment: Strong Buy
AI
